Brandie Taylor

7PUBLICATIONS
54CO-AUTHORS
Innate immunityImmunogenetics (incl. genetic immunology)Biologically active moleculesNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 10, 2025
Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance.

Ann Hanna, Xiaopeng Sun, Quanhu Sheng

|Oct 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.

Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann

|Jun 11, 2025
Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody-STING agonist conjugates.

Blaise R Kimmel, Karan Arora, Neil C Chada

|May 20, 2024
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy.

John Wilson, Blaise Kimmel, Karan Arora

|Apr 30, 2024
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.

Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson

|Feb 05, 2024
Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance.

Jamaal L James, Brandie C Taylor, Margaret L Axelrod

Pageof 2

Frequent Collaborators

7 joint publications

Justin M Balko

4 joint publications

Xiaopeng Sun

3 joint publications

Paula I Gonzalez-Ericsson

3 joint publications

Violeta Sanchez